Bookmark

Add to MyYahoo RSS

DanaFarber Cancer Institute News

News on DanaFarber Cancer Institute continually updated from thousands of sources around the net.

4 hrs ago | Voice of America

Scientists Identify Cause of Cancer Wasting

Many become so frail, they cannot safely undergo potentially life-saving treatments./p pNow researchers have discovered a molecule that appears to be responsible for this condition, known as cachexia.

Comment?

Related Topix: Hospital Administration, Medicine, Healthcare Industry

Thu Jul 10, 2014

Freshnews

GlycoMimetics Appoints Mark A. Goldberg, M.D. to Board of Directors

GAITHERSBURG, Md. -- -- GlycoMimetics, Inc. announced today the addition of Mark A. Goldberg, M.D. to its Board of Directors.

Comment?

Related Topix: Gaithersburg, MD, Synageva BioPharma, Medicine, Brigham and Women's Hospital, Hospital Administration, Healthcare Industry, Oncology, Hematology

SouthCoastToday.com

Lakeville's Bob Friedman hits the quarter million mark in Pan-Mass Challenge donations

The Lakeville resident, who practiced medicine in Middleboro for 34 years before entering semi-retirement, has raised $250,000 since 2000 for the Dana Farber Cancer Institute.

Comment?

Related Topix: Middleboro, MA, Medicine, Cancer, Health, Hospital Administration, Healthcare Industry, Provincetown, MA

Wed Jul 09, 2014

Boston.com

Scientists publish a deep look at DNA mutations in lung cancer

The largest and most comprehensive genomic study of the most common kind of lung cancer has revealed an exhaustive library of mutations carried by tumors, providing information that could help guide scientists' efforts to devise new treatments.

Comment?

Related Topix: Health, Lung Cancer, Medicine, Hospital Administration, Healthcare Industry

SeacoastOnline

York residents will ride in Pan-Mass Challenge

Four residents from York will participate in the 35th annual Pan-Mass Challenge on August 2-3, the largest single athletic fundraising event in the country.

Comment?

Related Topix: Hospital Administration, Medicine, Healthcare Industry, Massachusetts, Massachusetts Government

Wed Jul 02, 2014

The Washington Post

Dimon's Cancer Has 90% Cure Rate With Demanding Therapy: Health

The type of cancer Jamie Dimon has is curable in as many as 90 percent of cases with a treatment regimen that poses challenges for his demanding work schedule as chairman and chief executive officer of JPMorgan Chase & Co.

Comment?

Related Topix: Medicine, Cancer, Health, Memorial SloanKettering Cancer Center, Hospital Administration, Healthcare Industry, Oncology, Esophageal Cancer, Oral Cancer

Thu Jun 26, 2014

BioResearch Online

J&J Enters Cancer Research Partnership With Dana-Farber Cancer Institute

Johnson & Johnson Innovation and Janssen Biotech recently announced a three year immuno-oncology lung cancer collaboration with the Dana-Faber Cancer Institute's Belfer Institute for Applied Cancer Science.

Comment?

Related Topix: Medicine, Cancer, Health, Oncology, Food, J and J Snack Foods, Hospital Administration, Healthcare Industry, Lung Cancer

Tue Jun 24, 2014

Business Journal

Johnson & Johnson Innovation Center to fund $10 million Janssen Biotech, Dana-Farber partnership

A week after announcing partnerships with six Massachusetts-based companies, Johnson & Johnson Innovation Center said it will fund a $10 million partnership with Janssen Biotech, Inc. and Dana-Farber Cancer Institute to do work on lung cancer immunotherapy drugs.

Comment?

Related Topix: Hospital Administration, Medicine, Healthcare Industry, Health, Lung Cancer, Oncology

Thu Jun 19, 2014

EurekAlert!

Scientists identify additional challenges in KRAS-driven cancers

Cancers driven by - and dependent on - the potent mutated cancer gene KRAS have an especially poor prognosis, and three decades of scientific attempts have failed to produce drugs that can attack KRAS and halt the tumors' runaway growth.

Comment?

Related Topix: Medicine, Hospital Administration, Healthcare Industry, Frederick, MD

Mon Jun 16, 2014

BioSpace

Cellceutix Clinical Trial Of Anti-Cancer Drug Kevetrin Entering Eighth Cohort

Cellceutix Corporation , a clinical stage biopharmaceutical company developing innovative therapies in oncology, dermatology, and antibiotic applications, is pleased to report that the safety committee overseeing the Phase 1 clinical trial evaluating Cellceutix's lead anti-cancer drug Kevetrin for solid tumors being conducted at Dana-Farber Cancer ... (more)

Comment?

Related Topix: Healthcare Law, Law, Oncology, Medicine, Dermatology, Beth Israel Deaconess Medical Center, Hospital Administration, Healthcare Industry, Food and Drug Administration

Medical News

Trovagene enters into clinical collaboration with Dana-Farber Cancer Institute

Trovagene, Inc. today announced that it has entered into a clinical collaboration with Dana-Farber Cancer Institute to investigate the utility of quantitative urine-based mutation detection and the ability to monitor tumor mutation burden and treatment response over time in metastatic melanoma patients.

Comment?

Related Topix: Medicine, Cancer, Health, Hospital Administration, Healthcare Industry, Luke, MD, Oncology

Fri Jun 13, 2014

Business Wire

Publicity Club of New England Presents Pan-Mass Challenge with $2,000 Check

Each year, the host of the Bell Ringer Awards selects a charity to donate proceeds from the event.

Comment?

Related Topix: Public Relations, Hospital Administration, Medicine, Healthcare Industry

•••
•••
•••
•••

Seattle Jobs

•••
•••
•••
•••